Brian Maurice Foxwell

Title: **The Innovations of Brian Maurice Foxwell**

Introduction

Brian Maurice Foxwell is a prominent inventor based in Hounslow, GB. With a total of three patents to his name, he has made significant contributions to the field of biochemistry and therapeutic applications.

Latest Patents

One of Foxwell's latest innovations involves the development of radio-labelling of proteins utilizing nucleoside thiotriphosphates carrying .sup.32 P in the gamma-thiophosphate group. This process, developed through the reaction between a nucleoside diphosphate and a .sup.32 P labelled thiophosphate salt, is designed for use as thiophosphorylating agents in antibodies that target tumour-associated antigens. The labelled thiotriphosphates enable the introduction of a therapeutically beneficial .sup.32 P atom into modified antibodies. These modifications include the incorporation of a peptide region that functions as a substrate for a phosphokinase. The result is a labelled antibody that offers clinical advantages for anti-tumour therapies over standard phosphorylated analogues.

Career Highlights

Foxwell has had a distinguished career, showcasing his expertise in biochemistry through his innovative patents. His work is not only instrumental at a scientific level but also pioneers therapeutic approaches in cancer treatment, reflecting advances in medical technology.

Collaborations

Throughout his career, Brian Maurice Foxwell has collaborated with notable individuals, including Peter Parker and Andrew M Creighton. These collaborations have likely played a role in enhancing his innovative ideas and the successful execution of his patents.

Conclusion

In summary, Brian Maurice Foxwell stands out as a notable inventor with impactful contributions to medical science. His latest patents leverage sophisticated biochemical methods to improve cancer treatment therapies, establishing him as an influential figure in the realm of innovations and inventions.